In today’s podcast, Dr Catherine Bacus explores the Lancet Commission’s redefinition of obesity as a disease, highlighting its health impact, early intervention, reduced stigma, and policy implications.
Dr Rupert Hinds, Gastroenterologist discusses early life influences on the gut microbiota of children and the potential role of human milk oligosaccharides (HMOs).
In this Product Explainer, Endocrinologist A/Prof Sarah Glastras explains the role of Contrave (naltrexone hydrochloride / bupropion hydrochloride) tablets as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients ≥ 30 kg/m2 (obese), or ≥ 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of one or more weight-related comorbidities.
In this Product Explainer, Geriatrician A/Prof Michael Woodward AM explains the role of a medical food in the management of patients with mild cognitive impairment (MCI).
In this Product Explainer, General Practitioner Dr Gary Deed explains the role of Diabetes Specific Nutritional Formulas (DSNFs) and presents some cases to demonstrate their use in general practice.
Dr Rupert Hinds, Gastroenterologist, looks at a case of an infant with colic, identifies strategies, and offers a framework for identifying red flags and concerns.